VIRAL GENE THERAPY FOR MENKES DISEASE

NIH RePORTER · NIH · N01 · $91,138 · view on reporter.nih.gov ↗

Abstract

Currently, the National Institute of Neurological Disorders and Stroke (NINDS), via its URGenT network, is funding a cooperative agreement for the pre-clinical animal safety, efficacy, and toxicology studies for the treatment of Menkes disease.

Key facts

NIH application ID: 11215799
Project number: 75N95022D00021-0-759502400003-1
Recipient: BATTELLE CENTERS/PUB HLTH RES & EVALUATN
Principal Investigator: Amanda Burnaugh
Activity code: N01
Funding institute: NIH
Fiscal year: 2024
Award amount: $91,138
Award type: —
Project period: 2024-09-30 → 2027-09-29